Publication of decision to revoke the PBS approval - Kea & J Pharmacy Co Pty Ltd

Overview

The National Health Act 1953 was enacted by the Commonwealth Parliament to regulate the supply of pharmaceutical benefits and provide a framework for the administration of the Pharmaceutical Benefits Scheme (PBS). This Act was introduced to address issues related to the regulation of pharmaceutical services, ensuring that only qualified and compliant entities can supply PBS medicines. The Act provides the Minister for Health and Ageing with the authority to revoke PBS approvals when there are serious breaches of the legislation or unfitness to hold such approval. In this case, the Minister revoked the PBS approval of Kea & J Pharmacy Co Pty Ltd, effective from 26 September 2025, following findings of serious and repeated contraventions of the Act, including submitting unsupported claims, making false statements, misusing Commonwealth funds, and failing to attend a convened hearing. The revocation aims to maintain the integrity of the PBS, safeguard public funds, and ensure that only pharmacies complying with legislative requirements can supply PBS medicines.

Scope and Application

The National Health Act 1953 applies to entities and individuals approved to supply Pharmaceutical Benefits Scheme (PBS) medicines, ensuring compliance with federal health legislation. This Act specifically pertains to Kea & J Pharmacy Co Pty Ltd, an entity that was approved to supply PBS medicines at a particular location in Woodberry, NSW. The Minister for Health and Ageing has the authority to investigate and revoke approvals if an entity engages in conduct that constitutes an abuse of its approval, contravenes the Act, or demonstrates unfitness to hold such an approval. The revocation is effective as of 26 September 2025 and was taken following a thorough investigation by the Pharmaceutical Services Federal Committee of Inquiry. The Minister's decision to revoke the approval was published in the Gazette under section 134A of the NH Act, which allows for the disclosure of such actions to deter similar conduct and protect the integrity of the PBS. This action underscores the commitment to maintaining high standards of compliance and safeguarding the public interest in the PBS.

Key Provisions

The National Health Act 1953 (NH Act) contains several key provisions that are relevant to the revocation of Kea & J Pharmacy Co Pty Ltd's Pharmaceutical Benefits Scheme (PBS) approval. Sections 92A(1)(f), 103(5)(g), 103(5)(h), and 128(1) of the NH Act were specifically cited in the decision to revoke the approval due to serious and repeated contraventions by the pharmacy. These sections pertain to the submission of claims that are not supported by valid prescriptions or lawful supplies, making false or misleading statements in PBS claims, abusing the approval, and failing to attend a hearing despite being summoned. The Minister for Health and Ageing was satisfied that these actions constituted an abuse of the approval and demonstrated that Kea & J Pharmacy Co Pty Ltd was unfit to continue to hold a PBS approval. The NH Act imposes specific obligations on entities holding PBS approvals, including the requirement to submit claims that are supported by valid prescriptions and lawful supplies, to make accurate and truthful statements in PBS claims, and to attend any hearings convened by the relevant authorities. Kea & J Pharmacy Co Pty Ltd failed to meet these obligations, leading to the investigation and eventual revocation of its approval. The obligations also include using Commonwealth funds appropriately and not abusing the trust placed in the entity to supply PBS medicines to the community. Failure to comply with the provisions of the NH Act can result in serious consequences, including the revocation of PBS approval. Section 95 of the NH Act empowers the Minister, after investigation and report by a committee of inquiry, to revoke an approval where the pharmacist has engaged in conduct that constitutes an abuse of approval, contravenes the Act, or shows unfitness to continue to hold approval. In this case, the Minister for Health and Ageing revoked the approval of Kea & J Pharmacy Co Pty Ltd due to serious and repeated contraventions of the NH Act. Section 134A of the NH Act also authorises the Minister (or his delegate) to publish particulars of such action, including reasons, in the Gazette, in the public interest to discourage similar conduct and uphold the integrity of the PBS. The public interest statement accompanying the revocation highlights the importance of maintaining strict compliance standards to preserve equitable access to medicines and sustain confidence in Australia’s health system.